AI English summary of an SEC filing — figures as filed
The company said net sales for Q3 fell 8% to $1.67 billion (on a March 31, 2025 basis). It cited the divestitures of the VMS and Argentina businesses as the main factors. It said organic sales decreased 2% and organic volume was flat.
Key points
AI summaryThe company said net sales for Q3 fell 8% to $1.67 billion (on a March 31, 2025 basis). It cited the divestitures of the VMS and Argentina businesses as the main factors. It said organic sales decreased 2% and organic volume was flat.
The company said gross margin for Q3 rose 240 basis points to 44.6% (42.2% in the year-ago quarter). Diluted earnings per share were $1.50, compared with a loss of $0.41 in the year-ago quarter, and adjusted EPS fell 15% to $1.45 ($1.71 in the year-ago quarter).
The company said it expects full-year net sales for fiscal 2025 to decline 1% to be flat. It is guiding to organic sales growth of 4% to 5%, including an impact of 2 to 3 points from the ERP transition (previously 1 to 2 points). It said that excluding the ERP transition impact, organic sales would grow about 2%.
The company said it now expects full-year diluted EPS of $5.73 to $6.13 (previously $5.52 to $5.92). It said adjusted EPS is expected to be between $6.95 and $7.35, unchanged from its prior outlook range.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.
Clorox: Q3 Net Sales Fall 8%, Organic Sales Down 2%
The company said net sales for Q3 fell 8% to $1.67 billion (on a March 31, 2025 basis). It cited the divestitures of the VMS and Argentina businesses as the main factors. It said organic sales decreased 2% and organic volume was flat.
Source · Based on the filing body and exhibits
Q3 gross margin 44.6%, adjusted EPS $1.45
The company said gross margin for Q3 rose 240 basis points to 44.6% (42.2% in the year-ago quarter). Diluted earnings per share were $1.50, compared with a loss of $0.41 in the year-ago quarter, and adjusted EPS fell 15% to $1.45 ($1.71 in the year-ago quarter).
Source · Based on the filing body and exhibits
Updates full-year outlook; organic sales 4% to 5% growth
The company said it expects full-year net sales for fiscal 2025 to decline 1% to be flat. It is guiding to organic sales growth of 4% to 5%, including an impact of 2 to 3 points from the ERP transition (previously 1 to 2 points). It said that excluding the ERP transition impact, organic sales would grow about 2%.
Source · Based on the filing body and exhibits
Clorox Full-Year Diluted EPS $5.73 to $6.13, Adjusted EPS Range Maintained
The company said it now expects full-year diluted EPS of $5.73 to $6.13 (previously $5.52 to $5.92). It said adjusted EPS is expected to be between $6.95 and $7.35, unchanged from its prior outlook range.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…